Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Phoqus Pharmaceuticals Limited

Phoqus is a leading-edge drug delivery company providing a range of innovative and patented drug delivery systems based on electrostatic dry powder deposition technology.
The Phoqus systems are applicable across the entire product lifecycle:
Enabling the launch of a new chemical entity
Differentiating a product within a crowded market
Extending the product lifecycle via launch of alternative
formulations

We work with leading pharmaceutical companies to provide drug delivery solutions that:
Improve therapeutic efficacy
Enhance tolerability and reduce side effects
Make drugs more convenient for patients to take
Create distinctive brand images and identities
Provide more than 15 years of patent protection

Phoqus offers a comprehensive drug delivery service from feasibility studies and development programmes, through to clinical trials manufacture and full-scale production. Our aim is to provide innovation, service and value throughout the product lifecycle.


Contact Details:
10 Kings Hill Avenue, Kings Hill
West Malling
Kent
ME19 4PQ
United Kingdom
Tel:44 (0)1732 870227
Fax:44 (0)1732 870228
Email:info@phoqus.com
WWW:

www.phoqus.com/




Loading...

Recent Publications by Phoqus Pharmaceuticals Limited:

Colloidal stability of carbon nanotubes in an aqueous dispersion of phospholipid.
Within the family of nanomaterials, carbon nanotubes (CNTs) have emerged...
13th February, 2008
Phoqus Pharmaceuticals Limited, Kent, UK. Int J Nanomedicine. 2007;2(4):761-6.
Adaptive neuro-fuzzy modeling of poorly soluble drug formulations.
PURPOSE: The purpose of this study was to evaluate the efficiency of a...
14th February, 2007
Phoqus Pharmaceuticals Limited, 10 Kings Hill Avenue, Kings Hill, West Pharm Res. 2006 Jun;23(6):1157-64. Epub 2006 May 25.
DOI Direct Link

Press Releases on Phoqus Pharmaceuticals Limited:

BioPortfolio Logo
PHARMA LICENSE EXCHANGE® pre-event information exchange, start date 1st January, 1970 Pharlex
PHARMA LICENSE EXCHANGE® pre-event information exchange, start date announced Montalier International Ltd. announced today that the pre-event information exchange that precedes the
Pharma License Exchange™ North America's most efficient partnering 1st January, 1970 Pharlex
  North America's most efficient partnering forum  

BioNews Results for Phoqus Pharmaceuticals Limited:

Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
Pharma Live:  Sep 17 2009 2:42PM Matching: phoqus pharmaceuticals

Phoqus Pharmaceuticals Limited Patents:

US Patent No.Title
7384661 Electrostatic application of powder material to solid dosage forms in an electric field
7285303 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate
7153538 Method and apparatus for the coating of substrates for pharmaceutical use
7144597 Electrostatic application of powder material to solid dosage forms utilizing an electrically conductive shield
7070656 Electrostatic coating

View more Phoqus Pharmaceuticals Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 250 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in West Malling

Search for more companies in Kent



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phoqus Pharmaceuticals Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.